• NVP-BGJ398 Phosphate: FGFR3 Research Guide

  2026-09-11

  NVP-BGJ398 phosphate is a selective pan-FGFR1–3 inhibitor that blocks receptor autophosphorylation and downstream signaling. Preclinical evidence supports its use in FGFR-driven cancer models and in SLC26A2-related chondrodysplasia research, but these findings do not establish clinical efficacy.

• DiscoveryProbe Stem Cell Compound Library Plus Workflow

  2026-09-11

  DiscoveryProbe™ Stem Cell Compound Library Plus turns broad pathway coverage into a practical workflow for stem cell differentiation, self-renewal, and mechanism-guided phenotypic screening. Its strongest advantage is the combination of high-content imaging, pathway-focused perturbations, and orthogonal validation that distinguishes genuine cell-state changes from nonspecific toxicity.

• Pentoxifylline Workflows for Inflammation Research

  2026-09-10

  Build reproducible Pentoxifylline assays for cytokine suppression, macrophage activation, and topical psoriasis models. A formulation-focused workflow shows how niosome delivery can shift the endpoint from systemic exposure toward controlled skin deposition.

• Pioglitazone for Reliable Cell Assays

  2026-09-10

  This scenario-driven guide explains how Pioglitazone, SKU B2117, can support reproducible PPARγ, viability, macrophage-polarization, and metabolic research workflows. It connects formulation, assay controls, published DSS-model evidence, and practical vendor-selection criteria without confusing receptor activation with cytotoxicity.

• Tetrahedral DNA Frameworks Improve Enzymatic Synthesis

  2026-09-09

  The reference study shows that tetrahedral DNA nanostructures can organize primers at a defined interface, improving enzyme accessibility, catalytic behavior, and oligonucleotide synthesis fidelity. Its application to DNA information storage demonstrates how nanoscale primer presentation may address deletion errors in enzymatic oligonucleotide synthesis.

• T0070907: A Practical PPARγ Antagonist Workflow

  2026-09-09

  T0070907 gives researchers a high-affinity chemical switch for testing PPARγ-dependent transcription, adipogenesis inhibition, macrophage signaling, and cell-cycle responses. This workflow connects receptor pharmacology with the RXRα/PPARγ/NEDD4 axis while emphasizing solvent control, pathway validation, and separation of receptor-specific effects from cytotoxicity.

• Ceftazidime: A Resistance-Aware Research Framework

  2026-09-08

  Ceftazidime is a third-generation cephalosporin whose activity can be interpreted more intelligently when antibiotic testing is integrated with resistance-gene localization and transfer assays. This guide translates the 2025 Guangdong CREC study into practical decisions for Gram-negative bacterial infection research, especially respiratory surveillance.

• HATU for Peptide Synthesis: Workflow & Troubleshooting

  2026-09-07

  HATU enables rapid carboxylic acid activation for demanding peptide synthesis chemistry, small-molecule inhibitor assembly, and selected esterifications. This practical guide connects peptide coupling with DIPEA to assay-ready medicinal chemistry workflows, including parameter selection, workup, and troubleshooting.

• Sodium Salicylate in Stromal Signaling Research

  2026-09-07

  A translational perspective on using sodium salicylate as an NF-κB inhibitor to interrogate inflammatory and oxidative-stress biology alongside emerging strategies for pancreatic tumor-stroma remodeling.

• Rosemary Extract and Renal Amyloidosis Mechanisms

  2026-09-05

  This study integrates amyloid-fibril biophysics, renal cell models, and mouse pathology to examine how rosemary ethanol extract may counter renal amyloidosis. Its findings connect fibril disruption with calcium and reactive oxygen species control, suppression of PERK/ATF-4/CHOP endoplasmic reticulum stress, and reduced apoptosis, while also highlighting the limits of translating extract-based evidence into therapy.

• DiscoveryProbe Stem Cell Compound Library Plus Workflow

  2026-09-05

  DiscoveryProbe™ Stem Cell Compound Library Plus turns broad pathway coverage into a practical workflow for phenotypic screening, differentiation studies, and mechanism-guided validation. Its strongest use case is pairing high-content imaging with viability, lineage, and target-proximal assays so researchers can distinguish meaningful cell-state changes from nonspecific toxicity.

• NEDD4L, PRMT5, and CRC Liver Metastasis

  2026-09-04

  The reference study uses an in vivo E3-ligase screen to identify NEDD4L as a suppressor of colorectal cancer liver metastasis. Its mechanistic model connects NEDD4L-dependent PRMT5 degradation with reduced AKT1 arginine methylation and inhibition of AKT/mTOR signaling, providing a framework for studying metastatic colonization.

• Gemcitabine HCl: From DNA Damage to MRI

  2026-09-04

  Gemcitabine HCl research is strongest when molecular cytotoxicity and longitudinal tumor imaging are interpreted together. This article presents a decision-focused framework linking DNA replication inhibition, apoptosis, and multianimal MRI in pancreatic cancer models.

• T0070907: A Practical PPARγ Antagonist Guide

  2026-09-03

  T0070907 is a nanomolar PPARγ antagonist for separating receptor-dependent transcription from downstream phenotypes. This guide connects assay design, adipogenesis inhibition, PPARγ/RXRα heterodimer modulation, and cancer-cell-cycle workflows with practical controls and troubleshooting.

• Cyclopamine: From Hedgehog Mechanism to Translation

  2026-09-02

  A translational framework for using Cyclopamine to interrogate Smoothened-dependent biology, validate tumor responses, manage developmental risk, and connect pathway perturbation with emerging insights into inflammatory gene regulation.

8020 records 1/535 page Next 12345 下5页 Last page